Chemo-resistant gestational trophoblastic neoplasia and the use of immunotherapy: A case report and review of literature.
https://doi.org/10.47895/amp.v58i11.8008
- Author:
Elizabeth K. Jacinto
1
Author Information
1. Division of Trophoblastic Diseases, Department of Obstetrics and Gynecology, College of Medicine and Philippine General Hospital, University of the Philippines Manila
- Publication Type:Journal Article
- Keywords:
Chemo-resistance;
Immune-related Adverse Events
- MeSH:
Gestational Trophoblastic Disease;
Choriocarcinoma;
Pembrolizumab
- From:
Acta Medica Philippina
2024;58(11):90-98
- CountryPhilippines
- Language:English
-
Abstract:
This is the first reported case of the use of immunotherapy in chemo-resistant Gestational Trophoblastic Neoplasia (GTN) in the country. A 41-year-old, Gravida 4 Para 3 (3013) with a diagnosis of GTN, Stage III: WHO risk score of 13 (Choriocarcinoma) was initially managed with 10 cycles of multiple agent Etoposide, Methotrexate, Actinomycin D- Cyclophosphomide and Vincristine (EMACO) and 19 cycles of Etoposide, Cisplatin- Etoposide Methotrexate and Actinomycin D (EP-EMA). With continuous rise in beta human chorionic gonadotropin (ßhCG) levels, the patient was referred to a Trophoblastic Disease Center where there was note of tumor progression to the brain. She was started on third-line salvage chemotherapy of Paclitaxel and Carboplatin (PC) with concomitant whole brain irradiation completing three cycles after which chemoresistance was again diagnosed with increasing hCG titers and increase in the number and size of the pulmonary masses which were deemed unresectable. Immunotherapy was started with Pembrolizumab showing a good response with marked fall in ßhCG levels. The onset of immune-related adverse events (irAEs) caused a marked delay in subsequent cycles of immunotherapy. With management of the irAEs, two more cycles of Pembrolizumab with fifty percent dose reduction were given with corresponding drop in ßhCG levels. However, the patient subsequently developed gram-negative septicemia with possible hematologic malignancy and finally succumbed to massive pulmonary embolism. The case highlights the importance of prompt diagnosis and referral to a Trophoblastic Disease Center and the use of immunotherapy in chemo-resistant GTN.
- Full text:202407260947502013912.pdf
